{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:28:13Z","timestamp":1790616493189,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General and Comparative Endocrinology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ygcen.2015.06.011","type":"journal-article","created":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T00:51:38Z","timestamp":1436316698000},"page":"119-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Growth hormone and cancer: GH production and action in glioma?"],"prefix":"10.1016","volume":"220","author":[{"given":"Robert W.","family":"Lea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos G.","family":"Martinez-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasra","family":"El-Abry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygcen.2015.06.011_b0005","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1210\/endo.140.7.6762","article-title":"Growth hormone-mediated regulation of insulin-like growth factor I promoter activity in C6 glioma cells","volume":"140","author":"Benbassat","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.ygcen.2015.06.011_b0010","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ghir.2008.05.005","article-title":"Role of the GH\/IGF-1 axis in lifespan and healthspan: lessons from animal models","volume":"18","author":"Berryman","year":"2008","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ygcen.2015.06.011_b0015","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1365-2605.2010.01064.x","article-title":"Growth hormone affects gene expression and proliferation in human prostate cancer cells","volume":"34","author":"Bidosee","year":"2011","journal-title":"Int. J. Androl."},{"key":"10.1016\/j.ygcen.2015.06.011_b9000","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.biocel.2007.07.008","article-title":"Growth hormone receptor; mechanism of action","volume":"40","author":"Brooks","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ygcen.2015.06.011_b0020","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2265.2005.02338.x","article-title":"Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement","volume":"63","author":"Chung","year":"2005","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ygcen.2015.06.011_b0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrendo.2010.171","article-title":"Growth hormone, the insulin-like growth factor axis, insulin and cancer risk","volume":"7","author":"Clayton","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ygcen.2015.06.011_b0030","doi-asserted-by":"crossref","first-page":"13331","DOI":"10.1073\/pnas.0600181104","article-title":"Nuclear targeting of the growth hormone receptor results in dysregulation of cell proliferation and tumorigenesis","volume":"104","author":"Conway-Campbell","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ygcen.2015.06.011_b0035","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1055\/s-0029-1215591","article-title":"Hormones in the nucleus of mast cells: confocal microscopic immunocytochemical observations","volume":"41","author":"Csaba","year":"2009","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ygcen.2015.06.011_b0040","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1080\/08035250600577889","article-title":"Recurrence of brain tumours in patients treated with growth hormone: analysis of KIGS (Pfizer International Growth Database)","volume":"95","author":"Darendeliler","year":"2006","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ygcen.2015.06.011_b0045","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1055\/s-2007-1013563","article-title":"Elevated growth hormone levels in sera from breast cancer patients","volume":"17","author":"Emerman","year":"1985","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ygcen.2015.06.011_b0050","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/sj.cdd.4401872","article-title":"Chemotherapy resistance of glioblastoma stem cells","volume":"13","author":"Eramo","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ygcen.2015.06.011_b0055","first-page":"31","article-title":"Acromegaly: etiology, diagnosis and management","volume":"17","author":"Ezzat","year":"1991","journal-title":"Compr. Ther."},{"key":"10.1016\/j.ygcen.2015.06.011_b0060","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/toxsci\/kfm059","article-title":"Recombinant rat and mouse growth hormones: risk assessment of carcinogenic potential in 2-year bioassays in rats and mice","volume":"97","author":"Farris","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ygcen.2015.06.011_b0065","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1054\/ghir.2000.0183","article-title":"Growth hormone and insulin-like growth factor-I: effects on the growth of glioma cell lines","volume":"11","author":"Friend","year":"2001","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ygcen.2015.06.011_b0070","first-page":"77","article-title":"The inhibition of liver carcinogenesis with 3\u2032-methyl-4-dimethylaminoazobenzene in hypophysectomized rats","volume":"13","author":"Griffin","year":"1953","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygcen.2015.06.011_b0075","first-page":"53","article-title":"Interaction of insulin, polypeptide hormones, and growth factors with intracellular membranes","volume":"650","author":"Goldfine","year":"1981","journal-title":"Biochem. Biophys. Acta"},{"key":"10.1016\/j.ygcen.2015.06.011_b0080","doi-asserted-by":"crossref","first-page":"70ra13","DOI":"10.1126\/scitranslmed.3001845","article-title":"Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans","volume":"3","author":"Guevara-Aguirre","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ygcen.2015.06.011_b0085","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s12020-010-9403-8","article-title":"Extrapituitary growth hormone","volume":"38","author":"Harvey","year":"2010","journal-title":"Endocrine"},{"key":"10.1016\/j.ygcen.2015.06.011_b0090","unstructured":"Harvey, S., Dawson, T., Lea, R.W., 2009. Growth hormone production and action in glioma. In: Proceedings of British Society for Neuro-oncology, Hull, U.K."},{"key":"10.1016\/j.ygcen.2015.06.011_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/JMN:20:1:1","article-title":"Neural growth hormone: an update","volume":"20","author":"Harvey","year":"2003","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ygcen.2015.06.011_b9005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ygcen.2014.11.004","article-title":"Autocrine\/paracrine roles of extrapituitary growth hormone and prolactin in health and disease: an overview","volume":"220","author":"Harvey","year":"2015","journal-title":"Gen. Comp. Endocrinol."},{"issue":"Suppl.","key":"10.1016\/j.ygcen.2015.06.011_b0100","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1507\/endocrj.47.SupplMarch_S57","article-title":"Incidence of malignant tumors in patients with acromegaly","volume":"47","author":"Higuchi","year":"2000","journal-title":"Endocr. J."},{"key":"10.1016\/j.ygcen.2015.06.011_b0105","series-title":"The Molecular and Cellular Pathology of Cancer Progression and Prognosis","article-title":"Growth hormone and cancer","author":"Hull","year":"2006"},{"issue":"Suppl. 1","key":"10.1016\/j.ygcen.2015.06.011_b0110","first-page":"108","article-title":"Acromegaly and cancer","volume":"62","author":"Jenkins","year":"2004","journal-title":"Horm. Res."},{"key":"10.1016\/j.ygcen.2015.06.011_b0115","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/gut.44.5.585","article-title":"Colorectal neoplasia in acromegaly","volume":"44","author":"Jenkins","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.ygcen.2015.06.011_b9010","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1210\/endo.142.2.7936","article-title":"The effects of autocrine human growth hormone (hGH) on human mammary carcinoma cell behavior are mediated via the hGH receptor","volume":"142","author":"Kaulsay","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.ygcen.2015.06.011_b0120","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1073\/pnas.96.1.226","article-title":"Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone","volume":"96","author":"Kiaris","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ygcen.2015.06.011_b0125","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/sj.neo.7900074","article-title":"Antagonists of growth hormone-releasing hormone inhibit the growth of U-87MG human glioblastoma in nude mice","volume":"2","author":"Kiaris","year":"2000","journal-title":"Neoplasia"},{"key":"10.1016\/j.ygcen.2015.06.011_b0130","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.peptides.2010.07.006","article-title":"A correlation of endocrine and anticancer effects of some antagonists of GHRH","volume":"31","author":"Kovacs","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.ygcen.2015.06.011_b0135","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/jnci\/94.6.454","article-title":"Association of a common polymorphism in the human GH1 gene with colorectal neoplasia","volume":"94","author":"Le Marchand","year":"2002","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.ygcen.2015.06.011_b0140","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1530\/JOE-11-0100","article-title":"The effects of recombinant human GH on promoting tumor growth depend on the expression of GH receptor in vivo","volume":"211","author":"Lin","year":"2011","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ygcen.2015.06.011_b0150","doi-asserted-by":"crossref","unstructured":"Marek, B., Kajdaniuk, D., Kos, K., z, s., a, B., Ostrowska, Z., Niedziol, ka, D., Janczewska-Kazek, E., 2001. Acromegaly and the risk of cancer. Pathophysiology 8, 69\u201375.","DOI":"10.1016\/S0928-4680(01)00078-5"},{"key":"10.1016\/j.ygcen.2015.06.011_b0155","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ygcen.2014.04.004","article-title":"Secretagogue induction of GH release in QNR\/D cells: prevention of cell death","volume":"203","author":"Martinez-Moreno","year":"2014","journal-title":"Gen. Comp. Endocrinol."},{"key":"10.1016\/j.ygcen.2015.06.011_b0160","first-page":"1397","article-title":"Decreased serum levels of insulin-like growth factor (IGF)-I in patients with lung cancer: temporal relationship with growth hormone (GH) levels","volume":"19","author":"Mazzoccoli","year":"1999","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ygcen.2015.06.011_b0165","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1210\/jcem-71-1-199","article-title":"Insulin-like growth factor-I receptors in human glial tumors","volume":"71","author":"Merrill","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ygcen.2015.06.011_b0170","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/jcb.24473","article-title":"Differential effects of exogenous and autocrine growth hormone on LNCaP prostate cancer cell proliferation and survival","volume":"114","author":"Nakonechnaya","year":"2013","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ygcen.2015.06.011_b0175","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1210\/endo-124-1-455","article-title":"The expression of a metallothionein-ovine growth hormone fusion gene in transgenic mice does not impair fertility but results in pathological lesions in the liver","volume":"124","author":"Orian","year":"1989","journal-title":"Endocrinology"},{"key":"10.1016\/j.ygcen.2015.06.011_b0180","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1210\/endo-128-3-1238","article-title":"Elevation of growth hormone (GH) and prolactin receptors in transgenic mice expressing ovine GH","volume":"128","author":"Orian","year":"1991","journal-title":"Endocrinology"},{"key":"10.1016\/j.ygcen.2015.06.011_b0185","first-page":"2730","article-title":"Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group","volume":"83","author":"Orme","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ygcen.2015.06.011_b0190","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1210\/jc.2013-4159","article-title":"Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the childhood cancer survivor study","volume":"99","author":"Patterson","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ygcen.2015.06.011_b0195","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ghir.2006.09.006","article-title":"The oncogenic potential of growth hormone","volume":"16","author":"Perry","year":"2006","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ygcen.2015.06.011_b9015","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10911-008-9070-z","article-title":"The contribution of growth hormone to mammary neoplasia","volume":"13","author":"Perry","year":"2008","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.ygcen.2015.06.011_b0200","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/MED.0b013e328363183a","article-title":"Growth hormone and cancer: an update on progress","volume":"20","author":"Perry","year":"2013","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.ygcen.2015.06.011_b9020","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.rvsc.2010.03.016","article-title":"Serum and intratumoural GH and IGF-I concentrations: prognostic factors in the outcome of canine mammary cancer","volume":"89","author":"Queiroga","year":"2010","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.ygcen.2015.06.011_b0205","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0039-6109(16)36638-5","article-title":"Hypophysectomy in treatment of disseminated breast cancer","volume":"42","author":"Ray","year":"1962","journal-title":"Surg. Clin. North Am."},{"key":"10.1016\/j.ygcen.2015.06.011_b0210","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/1097-0142(195309)6:5<1025::AID-CNCR2820060522>3.0.CO;2-1","article-title":"Adrenal histological change and liver-tumor inhibition in hypophysectomized rats fed the azo dye, 3\u2032-methyl-4-dimethylaminoazobenzene","volume":"6","author":"Richardson","year":"1953","journal-title":"Cancer"},{"key":"10.1016\/j.ygcen.2015.06.011_b0215","first-page":"1","article-title":"Growth hormone receptor expression in brain tumors","volume":"61","author":"Sakoguchi","year":"2012","journal-title":"Hiroshima J. Med. Sci."},{"key":"10.1016\/j.ygcen.2015.06.011_b0220","first-page":"1055","article-title":"Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro","volume":"28","author":"Schlenska-Lange","year":"2008","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ygcen.2015.06.011_b0225","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3390\/cancers3010621","article-title":"Treatment resistance mechanisms of malignant glioma tumor stem cells","volume":"3","author":"Schmalz","year":"2011","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ygcen.2015.06.011_b0230","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1074\/jbc.M113.523373","article-title":"Multimeric growth hormone complexes serve as signaling platforms","volume":"289","author":"Sedek","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ygcen.2015.06.011_b0235","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1272\/jnms.72.335","article-title":"Growth hormone enhances natural killer cell activity against glioma","volume":"72","author":"Shimizu","year":"2005","journal-title":"J. Nippon Med. Sch."},{"key":"10.1016\/j.ygcen.2015.06.011_b0240","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1530\/EJE-10-0859","article-title":"Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies","volume":"164","author":"Steuerman","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ygcen.2015.06.011_b9025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10911-008-9066-8","article-title":"Rational design of competitive prolactin\/growth hormone receptor antagonists","volume":"13","author":"Tallet","year":"2008","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"issue":"Suppl. 2","key":"10.1016\/j.ygcen.2015.06.011_b0245","article-title":"Increased fasting serum levels of growth hormone and gastrin in patients with gastric and large bowel cancer","volume":"50","author":"Triantafillidis","year":"2003","journal-title":"Hepatogastroenterology"},{"issue":"Suppl.","key":"10.1016\/j.ygcen.2015.06.011_b0250","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1507\/endocrj.47.SupplMarch_S33","article-title":"Recurrence of sellar and suprasellar tumors in children treated with hGH\u2013relation to immunohistochemical study on GH receptor","volume":"47","author":"Uchino","year":"2000","journal-title":"Endocr. J."},{"key":"10.1016\/j.ygcen.2015.06.011_b9030","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1210\/me.2007-0092","article-title":"Autocrine growth hormone: effects on growth hormone receptor trafficking and signaling","volume":"21","author":"van den Eijnden","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ygcen.2015.06.011_b0255","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1677\/erc.1.01073","article-title":"Association of polymorphisms and haplotypes in the human growth hormone 1 (GH1) gene with breast cancer","volume":"12","author":"Wagner","year":"2005","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ygcen.2015.06.011_b9035","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1210\/jc.2011-1245","article-title":"Tumor expression of human growth hormone and human prolactin predict a worse survival outcome in patients with mammary or endometrial carcinoma","volume":"96","author":"Wu","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ygcen.2015.06.011_b0260","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.biocel.2014.02.024","article-title":"Proliferating cell unclear antigen-associated factor (PAF15): a novel oncogene","volume":"50","author":"Xie","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ygcen.2015.06.011_b0265","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/sj.onc.1204113","article-title":"P15(PAF), a novel PCNA associated factor with increased expression in tumor tissues","volume":"25","author":"Yu","year":"2001","journal-title":"Oncogene"}],"container-title":["General and Comparative Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001664801500177X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001664801500177X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T02:23:25Z","timestamp":1566959005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001664801500177X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":60,"alternative-id":["S001664801500177X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygcen.2015.06.011","relation":{},"ISSN":["0016-6480"],"issn-type":[{"value":"0016-6480","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth hormone and cancer: GH production and action in glioma?","name":"articletitle","label":"Article Title"},{"value":"General and Comparative Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygcen.2015.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}